医学
表皮生长因子受体
化疗
内科学
外显子
肿瘤科
肺癌
癌症研究
癌症
生物
基因
遗传学
作者
Caicun Zhou,Kejing Tang,Byoung Chul Cho,Baogang Liu,Luís Paz-Ares,Susanna Y. Cheng,Satoru Kitazono,Muthukkumaran Thiagarajan,Jonathan W. Goldman,Joshua K. Sabari,Rachel E. Sanborn,Aaron S. Mansfield,Jen‐Yu Hung,Michael Boyer,Sanjay Popat,Josiane Mourão Dias,Enriqueta Felip,Margarita Majem,Mahmut Gümüş,Sang‐We Kim
标识
DOI:10.1056/nejmoa2306441
摘要
Amivantamab has been approved for the treatment of patients with advanced non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (
科研通智能强力驱动
Strongly Powered by AbleSci AI